Clinical Development Lead, Solid Tumor Oncology, BTC & GEA

Job Description

Jazz Pharmaceuticals is seeking a Clinical Development Lead for Solid Tumor Oncology in BTC & GEA. As part of the Oncology team, you will lead the late-stage development and life-cycle management of a key Oncology asset for Biliary Tract Cancer (BTC) and Gastroesophageal Adenocarcinoma (GEA). The role involves strategic leadership, clinical development planning, cross-functional collaboration, regulatory compliance, clinical trial oversight, data analysis, risk management, external collaboration, budget and resource management, and team development.

Responsibilities

• Provide strategic direction and leadership for clinical development programs.
• Develop comprehensive global clinical development plans for Oncology in the context of BTC and GEA.
• Collaborate with various teams to ensure seamless execution of clinical development programs.
• Ensure compliance with regulatory requirements and guidelines.
• Oversee the execution of clinical trials, data analysis, and risk management.
• Cultivate relationships with key opinion leaders and partners.
• Manage budget allocation and resource planning.
• Foster a high-performance culture within the team.

Requirements

• Demonstrable experience leading the development of a Solid Tumor Oncology asset successfully.
• Proven experience with developing high performing clinical development teams.
• Strong executive presence and communication skills.
• MD required, board-certified Oncologist preferred.
• Higher postgraduate degree preferred.
• Clinical and/or development experience in solid tumor oncology preferred.

Jazz Pharmaceuticals is an equal opportunity employer. US-based candidates only. Competitive compensation and benefits package including medical, dental, vision insurance, 401k plan, and flexible paid vacation.